These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5460188)

  • 21. [EFFECTS OF PHENOXYBENZAMINE, PHENTOLAMINE AND AZAPETINE ON ADRENERGIC SYNAPSES OF THE CAT SPLEEN. BLOCKADE OF ALPHA-ADRENERGIC RECEPTORS AND INHIBITION OF RE-UPTAKE OF NEURALLY RELEASED NORADRENALINE].
    THOENEN H; HUERLIMANN A; HAEFELY W
    Helv Physiol Pharmacol Acta; 1964; 22():148-61. PubMed ID: 14246442
    [No Abstract]   [Full Text] [Related]  

  • 22. The antagonism of phentolamine against exogenously administered and endogenously released norepinephrine in rabbit aortic strips.
    Urquilla PR; Stitzel RE; Fleming WW
    J Pharmacol Exp Ther; 1970 Apr; 172(2):310-9. PubMed ID: 4315002
    [No Abstract]   [Full Text] [Related]  

  • 23. The removal of noradrenaline in the pulmonary circulation of rat isolated lungs.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1973 Feb; 47(2):325-31. PubMed ID: 4722046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the potency of dibenzyline, ilidar, phentolamine (regitine) and tolazoline (priscoline) in blocking the vasoconstrictor responses in canine muscle to lumbar sympathetic stimulation and to intra-arterial injections of L-epinephrine and of L-norepinephrine.
    GREEN HD; DENISON AB; WILLIAMS WO; GARVEY AH; TABOR CG
    J Pharmacol Exp Ther; 1954 Dec; 112(4):462-72. PubMed ID: 13222239
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of tritiated phenoxybenzamine for investigating receptors.
    Lewis JE; Miller JW
    J Pharmacol Exp Ther; 1966 Oct; 154(1):46-55. PubMed ID: 5951060
    [No Abstract]   [Full Text] [Related]  

  • 26. Inactivation of endogenous noradrenaline released by electrical stimulation in vitro of dog saphenous vein.
    Brandão F; Guimarães S
    Blood Vessels; 1974; 11(1-2):45-54. PubMed ID: 4447847
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation.
    Dubocovich ML; Langer SZ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):83-101. PubMed ID: 933013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of "heavy" phenamines on alpha- and beta-adrenoreceptors].
    Kadyrova DM; Bobkov IuG
    Farmakol Toksikol; 1969; 32(1):50-3. PubMed ID: 4388898
    [No Abstract]   [Full Text] [Related]  

  • 29. Interference of membrane pump blocking and alpha-receptor blocking drugs with noradrenaline release from isolated tissues.
    Farneboe LO; Hamberger B
    Acta Physiol Scand; 1970 Dec; 80(4):38A-39A. PubMed ID: 4395437
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metabolic effects of Catapres].
    Rehbinder D; Deckers W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(2):162-75. PubMed ID: 4235048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modeling of the interaction of catecholamines with alpha-adrenoreceptors].
    Manukhin BN; Viaz'mina NM
    Fiziol Zh SSSR Im I M Sechenova; 1971 Mar; 57(3):372-9. PubMed ID: 5560414
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition by phenoxybenzamine of the noradrenaline releasing effect of tyramine.
    Hedqvist P; Oliverio A; Stjärne L
    Acta Physiol Scand; 1968 Apr; 72(4):385-91. PubMed ID: 5664029
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.
    Cubeddu L; Barnes EM; Langer SZ; Weiner N
    J Pharmacol Exp Ther; 1974 Sep; 190(3):431-50. PubMed ID: 4153469
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of nerve stimulation on the noradrenaline content of the spleen.
    Dearnaley DP; Geffen LB
    Proc R Soc Lond B Biol Sci; 1966 Dec; 166(1004):303-15. PubMed ID: 4382765
    [No Abstract]   [Full Text] [Related]  

  • 35. Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat.
    Green RD; Fleming WW
    J Pharmacol Exp Ther; 1967 May; 156(2):207-14. PubMed ID: 6026252
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 37. Is epinephrine reversal a phenomenon purely of -adrenergic block?
    Kaul CL; Grewal RS
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):363-78. PubMed ID: 4399726
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential inhibition of 5-hydroxytryptamine (5-HT) mediated contraction of rat thoracic aortae by phentolamine and tolazoline: correlation with inhibition of 5-HT binding and calcium ion.
    Curro FA; Greenberg S
    Methods Find Exp Clin Pharmacol; 1983; 5(2):107-20. PubMed ID: 6876942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulating action of catecholamines on isolated preparations of the rat colon and human and rabbit taeniae coli.
    Belisle S; Gagnon DJ
    Br J Pharmacol; 1971 Feb; 41(2):361-6. PubMed ID: 5572281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for studying release of prostaglandins from superfused strips of isolated spleen.
    Willis AL
    Br J Pharmacol; 1970 Feb; 38(2):470P-472P. PubMed ID: 5417893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.